Pfizer (PFE) Shares Outstanding (Diluted Average) (2009 - 2026)

Pfizer (PFE) has 17 years of Shares Outstanding (Diluted Average) data on file, last reported at $5.7 billion in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) changed 0.37% year-over-year to $5.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 billion (changed 0.37% YoY) and the FY2025 annual result came in at $5.7 billion, changed 0.23% from the prior year.
• Shares Outstanding (Diluted Average) steadied at $5.7 billion in Q1 2026 per PFE's latest filing, from $5.7 billion in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $5.8 billion in Q2 2022 and bottomed at $5.6 billion in Q4 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $5.7 billion (2025), against an average of $5.7 billion.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) gained 1.7%; it then dropped 1.45% in 2023.
• Tracing PFE's Shares Outstanding (Diluted Average) over 5 years: stood at $5.7 billion in 2022, then fell by 0.42% to $5.7 billion in 2023, then fell by 0.16% to $5.7 billion in 2024, then climbed by 0.23% to $5.7 billion in 2025, then gained by 0.32% to $5.7 billion in 2026.
• Per Business Quant, the three latest PFE Shares Outstanding (Diluted Average) figures stand at $5.7 billion (Q1 2026), $5.7 billion (Q4 2025), and $5.7 billion (Q3 2025).

Peer Comparison